Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 0.86 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.86 |
| ▸ | NPC1 | O15118 | 1/20 | 0.86 |
| ▸ | GMNN | O75496 | 1/20 | 0.86 |
| ▸ | USP2 | O75604 | 1/20 | 0.86 |
| ▸ | LMNA | P02545 | 1/20 | 0.86 |
| ▸ | TP53 | P04637 | 1/20 | 0.86 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.86 |
| ▸ | POLB | P06746 | 1/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.86 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.86 |
| ▸ | IDE | P14735 | 1/20 | 0.86 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.86 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.86 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3617723 | 1.00 | TRPV1 (1.00) | TRPV1MAPTHSD17B10MEN1KMT2A | |
| SCHEMBL30368905 | 1.00 | TRPV1 (1.00) | TRPV1MAPTHSD17B10MEN1KMT2A | |
| SCHEMBL30718914 | 1.00 | TRPV1 (1.00) | TRPV1MAPTHSD17B10MEN1KMT2A | |
| SCHEMBL30718949 | 1.00 | TRPV1 (1.00) | TRPV1MAPTHSD17B10MEN1KMT2A | |
| Palmitoyl Dopamine SCHEMBL30438287 | 1.00 | TRPV1 (1.00) | TRPV1MAPTHSD17B10MEN1KMT2A | |
| Palmitoyl Dopamine SCHEMBL875454 | 1.00 | TRPV1 (1.00) | TRPV1MAPTHSD17B10MEN1KMT2A | |
| SCHEMBL30582326 | 1.00 | TRPV1 (1.00) | TRPV1MAPTHSD17B10MEN1KMT2A | |
| SCHEMBL10617939 | 1.00 | TRPV1 (1.00) | TRPV1MAPTHSD17B10MEN1KMT2A | |
| SCHEMBL3325854 | 1.00 | TRPV1 (1.00) | TRPV1MAPTHSD17B10MEN1KMT2A | |
| SCHEMBL671000 | 1.00 | TRPV1 (1.00) | TRPV1MAPTHSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12377174-B2 | Magnetic nanoparticles functionalized with N-(3,4-dihydroxyphenethyl)dodecanamide, production and use thereof | COLOROBBIA ITALIA S.P.A. (IT) | 2025-08-05 | — | — | US | claimed |
| US-12262640-B2 | Piezoelectric device comprising a membrane comprising fibres of a polyhydroxyalkanoate | BIO ON S.P.A. (IT) | 2025-03-25 | — | — | US | claimed |
| EP-3903356-B1 | PIEZOELECTRIC DEVICE COMPRISING A MEMBRANE COMPRISING POLYHYDROXYALKANOATE FIBRES AND NANOPARTICLES | BIO ON SPA (IT) | 2024-11-27 | — | — | EP | claimed |
| EP-4558126-B1 | INJECTABLE SUSPENSION OR EMULSION OF COATED MAGNETITE NANOPARTICLES FOR USE IN THE TREATMENT OF SOLID TUMORS | VISION S P A (IT) | 2025-10-08 | — | — | EP | disclosed |
| US-12377174-B2 | Magnetic nanoparticles functionalized with N-(3,4-dihydroxyphenethyl)dodecanamide, production and use thereof | COLOROBBIA ITALIA S.P.A. (IT) | 2025-08-05 | — | — | US | disclosed |
| EP-4558126-A1 | INJECTABLE SUSPENSION OR EMULSION OF COATED MAGNETITE NANOPARTICLES FOR USE IN THE TREATMENT OF SOLID TUMORS | Vision S.p.A. (IT) | 2025-05-28 | — | — | EP | disclosed |
| WO-2024170735-A1 | INJECTABLE SUSPENSION OR EMULSION OF COATED MAGNETITE NANOPARTICLES FOR USE IN THE TREATMENT OF SOLID TUMORS | VISION S.P.A. (IT) | 2024-08-22 | — | — | WO | disclosed |
| EP-4417191-A1 | INJECTABLE SUSPENSION OR EMULSION OF COATED MAGNETITE NANOPARTICLES FOR USE IN THE TREATMENT OF SOLID TUMORS | Vision S.p.A. (IT) | 2024-08-21 | — | — | EP | disclosed |
| US-20230330273-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIA S.P.A. (IT) | 2023-10-19 | — | — | US | disclosed |
| US-20230330273-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIA S.P.A. (IT) | 2023-10-19 | — | — | US | disclosed |
| US-20210252171-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATECHOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIANA SPA (IT) | 2021-08-19 | — | — | US | disclosed |
| US-20210252171-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATECHOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIANA SPA (IT) | 2021-08-19 | — | — | US | disclosed |
| US-10888630-B2 | Magnetic nanoparticles functionalized with catechol, production and use thereof | COLOROBBIA ITALIA S.P.A. (IT) | 2021-01-12 | — | — | US | disclosed |
| US-10888630-B2 | Magnetic nanoparticles functionalized with catechol, production and use thereof | COLOROBBIA ITALIA S.P.A. (IT) | 2021-01-12 | — | — | US | disclosed |
| EP-3092012-B1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIANA SPA (IT) | 2019-06-19 | — | — | EP | disclosed |
| US-20160331850-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIA S.P.A. (IT) | 2016-11-17 | — | — | US | disclosed |
| US-20160331850-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIA S.P.A. (IT) | 2016-11-17 | — | — | US | disclosed |
| EP-3092012-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | Colorobbia Italia S.p.a. (IT) | 2016-11-16 | — | — | EP | disclosed |
| WO-2015104664-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIA S.P.A. (IT) | 2015-07-16 | — | — | WO | disclosed |
| US-20100129436-A1 | SUBTANCES FOR THE PROTECTION OF CELLS AND/OR TISSUES | LOSEL RALF | 2010-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100129436-A1 | SUBTANCES FOR THE PROTECTION OF CELLS AND/OR TISSUES | CTSA, BCL2, BAX | TRPV1 3411/4885MAPT 4257/4885HSD17B10 4248/4885 |
| US-20160331850-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | CD47, CD14, COMT | TRPV1 3806/4885MAPT 528/4885HSD17B10 3911/4885 |
| US-10888630-B2 | Magnetic nanoparticles functionalized with catechol, production and use thereof | CD47, CD14, COMT | TRPV1 4088/4885MAPT 254/4885HSD17B10 4150/4885 |
| US-12377174-B2 | Magnetic nanoparticles functionalized with N-(3,4-dihydroxyphenethyl)dodecanamide, production and use thereof | CD14, CD47, CD69 | TRPV1 2733/4885MAPT 520/4885HSD17B10 3415/4885 |
| US-20230330273-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | CD47, CD14, COMT | TRPV1 3806/4885MAPT 528/4885HSD17B10 3911/4885 |
| US-20210252171-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATECHOL, PRODUCTION AND USE THEREOF | CD47, CD14, COMT | TRPV1 4088/4885MAPT 254/4885HSD17B10 4150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.